Supernus Pharmaceuticals | Crediti Commerciali



Trade Debtors Cambiamento Data
Abbott USD 10.23B 562M 2025-06
ANI Pharmaceuticals USD 225.65M 5.32M 2025-06
Aurora Cannabis CAD 49.52M 9.36M 2024-12
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 64.57M 2.75M 2025-06
Eisai JPY 219.98B 42M 2025-06
Eli Lilly USD 17.21B 3.2B 2025-06
Novo Nordisk 90.28B 3.92B 2025-06
Pacira USD 114.37M 9.62M 2025-06
Perrigo USD 678.2M 38.6M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
Supernus Pharmaceuticals USD 140.83M 4.81M 2025-06
United Therapeutics USD 379.3M 57.3M 2025-06
Xeris Pharmaceuticals USD 40.42M 723K 2024-12


Supernus Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.